1. Home
  2. BG vs NBIX Comparison

BG vs NBIX Comparison

Compare BG & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BG
    SELLHOLDBUYas of 13 hours ago
  • NBIX
    SELLHOLDBUYas of 13 hours ago
  • Stock Information
  • Founded
  • BG 1818
  • NBIX 1992
  • Country
  • BG United States
  • NBIX United States
  • Employees
  • BG N/A
  • NBIX N/A
  • Industry
  • BG Packaged Foods
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BG Consumer Staples
  • NBIX Health Care
  • Exchange
  • BG Nasdaq
  • NBIX Nasdaq
  • Market Cap
  • BG 12.2B
  • NBIX 13.7B
  • IPO Year
  • BG N/A
  • NBIX 1996
  • Fundamental
  • Price
  • BG $77.28
  • NBIX $138.10
  • Analyst Decision
  • BG Buy
  • NBIX Buy
  • Analyst Count
  • BG 8
  • NBIX 22
  • Target Price
  • BG $118.00
  • NBIX $166.29
  • AVG Volume (30 Days)
  • BG 1.6M
  • NBIX 946.0K
  • Earning Date
  • BG 02-05-2025
  • NBIX 02-05-2025
  • Dividend Yield
  • BG 3.52%
  • NBIX N/A
  • EPS Growth
  • BG N/A
  • NBIX 97.40
  • EPS
  • BG 7.96
  • NBIX 3.73
  • Revenue
  • BG $54,502,000,000.00
  • NBIX $2,242,800,000.00
  • Revenue This Year
  • BG N/A
  • NBIX $27.07
  • Revenue Next Year
  • BG $2.05
  • NBIX $16.60
  • P/E Ratio
  • BG $9.70
  • NBIX $37.08
  • Revenue Growth
  • BG N/A
  • NBIX 25.72
  • 52 Week Low
  • BG $76.38
  • NBIX $110.95
  • 52 Week High
  • BG $114.92
  • NBIX $157.98
  • Technical
  • Relative Strength Index (RSI)
  • BG 29.68
  • NBIX 65.56
  • Support Level
  • BG $76.38
  • NBIX $136.01
  • Resistance Level
  • BG $78.77
  • NBIX $139.47
  • Average True Range (ATR)
  • BG 1.78
  • NBIX 3.32
  • MACD
  • BG -0.08
  • NBIX 0.05
  • Stochastic Oscillator
  • BG 12.40
  • NBIX 86.80

Stock Price Comparison Chart: BG vs NBIX

BG
NBIX
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025020406080100120140160BG VS NBIX

About BG Bunge Limited

Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes, and corn-based products in North and South America.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use